Phase I clinical trial of AXL1717 for treatment of relapsed malignant astrocytomas: analysis of dose and response. [electronic resource]
Publication details: Oncotarget Oct 2017Description: 81501-81510 p. digitalISSN:- 1949-2553
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.